Patent Term Extension Strategies for Biosimilars | McDermott

McDermott Will & Schulte, a global law firm

NEWSROOM

Patent Term Extension Strategies for Biosimilars

December 20, 2023

Read time: 2 min

Michael Siekman and Brennen Baylor contributed an article to the Intellectual Property & Technology Law Journal overviewing patent term extension strategies for biosimilars.

Brennen Baylor

Associate

Washington, DC

You may also like